Archives of Internal Medicine · 1987 · 172 citations · 15 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPsychopharmacologySubstance Use DisordersAddictionDopaminergic PharmacologyDrug DependenceSubstance WithdrawalWithdrawal ManagementWithdrawal SyndromesAgonist ActivityAmbulatory Withdrawal ManagementBromocriptine TreatmentDopamine PharmacodynamicsDouble-blind TrialsMonoamine PharmacologyPharmacologic Treatment Of WithdrawalPharmacological Management Of Withdrawal
Amantadine hydrochloride and bromocriptine mesylate were compared on a double-blind basis for withdrawal from cocaine dependence. Both amantadine and bromocriptine appear effective in alleviating the symptoms of cocaine withdrawal. In doses higher than previously reported, however, bromocriptine caused enough side effects to produce treatment dropouts; neither drug produced euphoria. Amantadine appears to primarily exert its therapeutic influence by releasing dopamine and norepinephrine from neuronal storage sites that are depleted by chronic cocaine dependence, and bromocriptine acts as a dopamine agonist and stimulates dopamine receptors.
15
Harriet de Wit, Roy A. Wise · Canadian Journal of Psychology/Revue Canadienne de Psychologie · 1977 · 494 citations
Medicine, Neuroscience, Pharmacology +16
Cortical Dopaminergic Involvement in Cocaine Reinforcement
Nick E. Goeders, James E. Smith · Science · 1983 · 489 citations
Medicine, Neuroscience, Pharmacology +17
Frank H. Gawin · Archives of General Psychiatry · 1984 · 292 citations
Scientific American · 1956 · 283 citations · Full text
Effect of Cocaine on the Disposition of Noradrenaline labelled with Tritium
L. G. Whitby, G. Hertting, J Axelrod · Nature · 1960 · 238 citations